Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

New hires at Crescendo, Healx and Galecto

New hires at Crescendo, Healx and Galecto

Before that, he lead global R&D at Almirall, which involved 500 staff and the development and approval of several new drugs in a number of therapy areas.

Almirall eyes $62m takeover of multicytokine specialist Bioniz

Almirall eyes $62m takeover of multicytokine specialist Bioniz Barcelona-based Almirall – which specialises in dermatology – says that the deal would expand its R&D pipeline with an additional three candidates on top of lead drug BNZ-1. ... Meanwhile, Almirall is in the launch phase for Ilumya/Ilumetri

Amgen buys Danish partner Nuevolution for $167m

Amgen buys Danish partner Nuevolution for $167m It will inherit established partnerships that Nuevolution also signed with the likes of Almirall, and Johnson &Johnson, according to the Danish firm’s website, and analysts at Edison said in March ... The Almirall partnership includes a RORγt

Big Pharma, Little Pharma

Big Pharma, Little Pharma And that’s exactly what comes out of my research. The recent industry announcement that triggered this thought was from Almirall, the Spanish pharma company with fewer than 2, 000 employees

Almirall acquires Allergan’s dermatology portfolio for $650m

Almirall acquires Allergan’s dermatology portfolio for $650m In a deal worth $650m, Spanish pharmaceutical company Almirall is set to buy Allergan’s US-based medical dermatology unit. ... If approved, Seysara could pull in predicted annual sales of $200m for Almirall.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics